ADCY9 Antikörper (AA 1029-1282)
Kurzübersicht für ADCY9 Antikörper (AA 1029-1282) (ABIN7567986)
Target
Alle ADCY9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1029-1282
-
Verwendungszweck
- Anti-ADCY9 Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human ADCY9 (Asp1029-Val1282).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- ADCY9 (Adenylate Cyclase 9 (ADCY9))
-
Andere Bezeichnung
- ADCY9
-
Hintergrund
- ADCY9,Adenylate cyclase type 9,AC9,ATP pyrophosphate-lyase 9,Adenylate cyclase type IX,ACIX,KIAA0520,Adenylyl cyclase 9,
-
UniProt
- O60503
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Target
-